Skip to main content

Advertisement

Table 3 miRNAs differentially expressed in early (I and II) vs late stage (III and IV) disease.

From: Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer

Sample ID Stage I/II Stage III/IV Fold change p-value
hsa-miR-31 7.11 9.97 7.22 1.53E-03
hsa-miR-7 7.77 8.85 2.11 1.96E-02
hsa-miR-99b 8.74 8.12 0.65 3.64E-03
hsa-miR-378* 6.85 6.23 0.65 3.02E-02
hsa-miR-133a 7.64 6.96 0.63 1.64E-02
hsa-miR-125a 10.64 9.76 0.54 2.69E-03
  1. Fold change = Stage III/IV:Stage I/II